MarketPeel
Insider Trading Intelligence
SG

Sydney A. Gilman

DMAC
VP, REGULATORY AFFAIRS · DIAMEDICA THERAPEUTICS INC. · CIK 0001793016
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
25,000
AVG SELL PX
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Sydney A. Gilman. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
DMAC · 25,000 shares · as of Jul 28, 2021
06,25012,50018,75025,0002021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
FLOW · 2 buys / 0 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
25,00025,000Jul 28, 2021Jul 29, 2021
DMAC
DIAMEDICA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
17,50017,500Jun 1, 2020Jun 2, 2020
Other insiders · DMAC
Loading peer insiders…
About this filer
CIK 0001793016
ROLE
VP, Regulatory Affairs
PRIMARY
DMAC
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001793016DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

FeedbackSydney A. Gilman — Insider Trading Activity | MarketPeel